KCNQ1OT1 and neoplasm: Knockdown of KCNQ1OT1 also reduced CAL27 and SCC9 cisplatin-resistant cell proliferation as well as tumor growth and weight in vivo via the miR-124-3p/TRIM14 axis [16].